Search
for
Sort by
Research 31–60 of 153
- Assessment of the obese patient
- DRUG‐ASSOCIATED ALOPECIA
- Adverse Cutaneous Reactions to Antidepressants
- Systemic treatments for alopecia areata: A systematic review
- Drug-Induced Hair Disorders
- Psychocutaneous disease
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Sexuality in premature ovarian insufficiency
- Trichotillomania: Clinical Aspects and Treatment Strategies *
- The placebo effect and randomized trials: analysis of conventional medicine
- Psychodermatology
- Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines
- The pathophysiology of delayed ejaculation
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Obsessive-compulsive disorder in dermatology
- Fatal Toxic Epidermal Necrolysis Associated with Minoxidil
- Dermatosis associated with menopause
- Effect of ethanol Adiantum capillus-veneris extract in experimental models of anxiety and depression
- Pharmacokinetic Interaction of Finasteride With Tamsulosin Hydrochloride: An Open-label, Randomized, 3-period Crossover Study in Healthy Chinese Male Volunteers
- Adverse cutaneous effects of psychotropic medications
- Medication Repurposing: New Uses for Old Drugs
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Update on psychodermatological disorders
- Diffuse Hair Loss Induced by Sertraline Use
- Psychotropic Treatment of Psychodermatologic Disorders
- Current and future pharmacotherapy for alopecia areata
- Diuretics
- Can gut flora changes be new biomarkers for depression?